There is exciting news in the field of osteoporosis. A new medication was FDA approved last month. Is this medication right for you? A... Read more »
Zoledronic acid, sold in the U.S. by Novartis under the brand name Reclast, just received final approval from the FDA for the treatment of... Read more »
Recently, the FDA approved the use of Reclast (zoledronic) acid for the treatment of osteoporosis. The bisphosphonate medication, known as... Read more »
The big buzz today is about a study in the New England Journal of Medicine touting the effectiveness of a drug taken intravenously just... Read more »
Reader Question: My doctor who has been treating me for osteoporosis told me that I should stop taking my medicine because my ‘bone... Read more »
The Food and Drug Administration has approved Reclast for sale on the U.S. market. Reclast is the first once-a-year treatment for osteoporosis. It is... Read more »
Osteoporosis is a disease that causes bones to weaken and break. The most common bones affected are the hip, wrist and vertebrae. Approximately 10... Read more »
Part III: Surviving Chemotherapy The Short and Long Of It Short-term side effects will subside after the last chemo dose – your hair will grow back... Read more »
Once-a-year injections of a common osteoporosis med could greatly reduce older women's fracture risk, a new study suggests. Researchers in Texas say... Read more »
(Ivanhoe Newswire) -- Postmenopausal women with osteoporosis may only need one dose of medication per year to reduce the risk of fractures. A new... Read more »